CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice ; volume:16 ; number:1 ; day:22 ; month:11 ; year:2021 ; pages:1-23 ; date:12.2021
Molecular neurodegeneration ; 16, Heft 1 (22.11.2021), 1-23, 12.2021
- Urheber
-
Bhargavan, Biju
Woollard, Shawna M.
McMillan, Jo Ellyn
Kanmogne, Georgette D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-021-00500-0
- URN
-
urn:nbn:de:101:1-2022013006001192014191
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bhargavan, Biju
- Woollard, Shawna M.
- McMillan, Jo Ellyn
- Kanmogne, Georgette D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Clinical use of CCR5 inhibitors in HIV and beyond
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Influence of smoking on HIV infection among HIV-infected Japanese men
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Clinical use of CCR5 inhibitors in HIV and beyond
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Influence of smoking on HIV infection among HIV-infected Japanese men
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Clinical use of CCR5 inhibitors in HIV and beyond
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Influence of smoking on HIV infection among HIV-infected Japanese men
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients